Results per Page:
BRCA1/2: Why men should be screened for the “breast cancer gene”
New research shows that men can carry mutations in the BRCA1 and BRCA2 genes that increase their risk of several cancers, but new national guidelines are helping to educate patients
When to do what to reduce your risk of cancer
A handy decade-by-decade guide for recommended screenings and other preventive actions
From predicted neoantigen to T cell therapy for acute myeloid leukemia
From the Bleakley Lab, Cancer Consortium and Translational Science & Therapeutics Division
How to survive the holidays with cancer
Scientists, providers and patients offer tips on getting through the season after a diagnosis
A Journey Through Our Genes: The Story of Prostate Cancer's Hidden Secrets
From the Darst research group, Public Health Sciences Division
RNA stability may play a role in prostate cancer
New research links mutations in RNA region that helps regulate protein production to progression and drug resistance
Navigating a cancer diagnosis while pregnant
Rare genetic mutation leads to cancer, treatment and vigilant screening for family
The cell’s two-pronged approach to mitigating genetic errors
From the Bradley Lab, Public Health Sciences and Basic Sciences Divisions
Good and surprising news finds germline mutations are rare in low-risk prostate cancer
From the Nelson Lab, part of the Human Biology and Public Health Sciences Divisions
Team of top researchers prepares for endemic COVID-19
$15M Howard Hughes Medical Institute grant shared by 8 scientists at Fred Hutch and UW
Two Fred Hutch postdocs named 2021 Damon Runyon Fellows
Awards to Drs. Edie Crosse and Ching-Ho Chang fund ‘creative, high-risk projects’ in cancer research
Outwitting the foe: predicting evolved antibody escape in SARS-CoV-2
From the Bloom Lab (Basic Sciences Division)
Mutated skin stem cells self-correct to prevent cancer
New study helps explain why inherited cancer-driving mutations don’t always lead to cancer
Your vote needed! Hutch science competes in 'STAT Madness'
Studies by Drs. Justin Taylor, Robert Bradley are finalists in annual competition for best biomedical advance
New research uncovers how common genetic mutation drives cancer
Findings in Nature show that targeted therapy for mutated gene can slow or prevent tumor growth in many kinds of cancer
How a common cancer mutation actually drives cancer — and how to correct it
High-tech approach solves ‘real mystery’ in many cancers
Highlights of Fred Hutch science in 2018
A look back at notable advances in immunotherapy, precision screening and more
Bringing personalized oncology to cancer prediction — and prevention
Unique $2.4M NCI-NIEHS award teams Hutch cancer geneticists, epidemiologists and oncologists to use mutation rate to predict individual cancer risk
The lung cancer blame game
The shame, blame and stigma surrounding this deadly disease affects everything from patient follow-through to research funding
Reawakening the X chromosome: New possible therapeutic targets for rare neurological disorder
Study points to potential reversal of rare childhood neurological disorder by reactivating silenced copy of the disease-linked gene